New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
Literature Review: Dielectrophoresis to the Fore
Old Methodology Resurrected to Allow Inexpensive Label-Free Separation of Cell Populations
Organ Donation: Opting In or Opting Out
As of January 1, all French citizens are now by law organ and tissue donors unless they put their names on a National Rejection Register. As of January 4, about 150,000 people signed the register to opt out of the system. France has a population of 66 million and approximately 19,000 individuals in that country are waiting for organ donations. In many countries, such as the U.S., organ donation works under an opt-in system.